FRAT1 Polyclonal Antibody

The protein encoded by this gene belongs to the GSK-3-binding protein family. The protein inhibits GSK-3-mediated phosphorylation of beta-catenin and positively regulates the Wnt signaling pathway. It may function in tumor progression and in lymphomagenesis.

The FRAT1 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of FRAT1 protein expression in various biological samples. This antibody has been meticulously developed and rigorously validated to ensure optimal performance and reliability.

The FRAT1 Polyclonal Antibody exhibits exceptional affinity and selectivity towards FRAT1, a key regulator of the Wnt signaling pathway. By targeting FRAT1, this antibody enables researchers to investigate the intricate mechanisms underlying Wnt signaling and its implications in various physiological and pathological processes.

This antibody is produced using state-of-the-art techniques, ensuring high purity and batch-to-batch consistency. It has been extensively tested in a variety of experimental settings, including Western blotting, immunohistochemistry, and immunofluorescence, demonstrating robust and specific staining patterns.

The FRAT1 Polyclonal Antibody is supplied as a liquid formulation, allowing for easy and convenient handling. It is provided in a range of sizes to accommodate different experimental needs. Each vial is carefully packaged to maintain the antibody's stability and integrity during shipping and storage.

With its exceptional performance and reliability, the FRAT1 Polyclonal Antibody is an indispensable tool for researchers studying the intricate mechanisms of Wnt signaling and its role in various biological processes.